These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7423736)

  • 1. [Immunological diagnosis of malignant melanomas of uveal tissue].
    Cernak A; Kalafut F; Hung PM
    Vestn Oftalmol; 1980; (5):60-3. PubMed ID: 7423736
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of the use of tumor immunity for the diagnosis and prognosis of malignant melanoma of uveal tissue].
    Cernák A; Kalafut F
    Cesk Oftalmol; 1983 May; 39(3):168-71. PubMed ID: 6347408
    [No Abstract]   [Full Text] [Related]  

  • 3. [The leukocyte adherence inhibition test in malignant melanoma of the uvea].
    Klein J; Dieckhues B; Küchle HJ
    Fortschr Ophthalmol; 1982 Nov; 79(3):202-3. PubMed ID: 6764445
    [No Abstract]   [Full Text] [Related]  

  • 4. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
    Kalafut F; Cernák A; Pham Manh Hung
    Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epibulbar lesions simulating extraocular extension of uveal melanomas.
    Donoso LA; Shields JA; Nagy RM
    Ann Ophthalmol; 1982 Dec; 14(12):1120-3. PubMed ID: 7165229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic aspects in the diagnosis of uveal melanoma].
    Omulecki W
    Klin Oczna; 1986 May; 88(5):175-7. PubMed ID: 3540439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological studies in intraocular tumors].
    Kotelianskiĭ EO
    Oftalmol Zh; 1982; 37(1):54-8. PubMed ID: 7043350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].
    Beutelspacher SC; Serbecic N
    Klin Monbl Augenheilkd; 2008 Aug; 225(8):703-7. PubMed ID: 18712654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
    Keijser S; Missotten GS; Bonfrer JM; de Wolff-Rouendaal D; Jager MJ; de Keizer RJ
    Br J Ophthalmol; 2006 Feb; 90(2):213-7. PubMed ID: 16424536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bilateral uveal melanomas. Five case reports].
    Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hierarchization of the prognostic factors in uveal malignant melanoma].
    Călugăru M; Mera M; Călugăru D
    Oftalmologia; 2000; 50(1):30-4. PubMed ID: 11021104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondiagnosed uveal melanomas.
    Bove R; Char DH
    Ophthalmology; 2004 Mar; 111(3):554-7. PubMed ID: 15019335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor immunity in patients with melanoma of the uveal tract].
    Cernák A; Kalafut F; Kusenda J; Novotná L
    Bratisl Lek Listy; 1989 Jul; 90(7):479-89. PubMed ID: 2790504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Further experience with the test of inhibition of leucocyte adherence (LAI) in the diagnosis of melanoblastomas of the choroid (author's transl)].
    Kubát Z; Sachsová D; Jandová A; Heyberger K; Andrysek O
    Sb Lek; 1979; 81(11-12):333-6. PubMed ID: 390683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.